Brigit Biofarmaka Teknologi Tbk. vs WIR ASIA Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while WIR ASIA Tbk. trades at Rp59 (market cap 644.69B, 389.81M 24h volume). The key difference: WIR ASIA Tbk. is far larger — about 3.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and WIR ASIA Tbk. is more actively traded (389.81M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | WIRG | |
|---|---|---|
Market Cap | 172.82B | 644.69B |
Volume | 592.2K | 389.81M |
Lot | 5.92K | 3.9M |
Turnover | 147.05M | 23.31B |
Average Price | 248.31 | 59.79 |
Value | 147.05M | 23.31B |
Indicative Equilibrium Price | 254 | 59 |
Indicative Equilibrium Volume | 10 | 53.29K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Read more on WIRG →